GlassScriptPhysician profile
Tiffany Seto
NPI 1649702036
$983.23
in general payments reported to CMS, 2019-2025
7 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $193 · 2024: $486 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $218.40 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Aadi Bioscience, INC. | $204.69 | 2023-2024 | Fyarro |
| Daiichi Sankyo INC. | $131.24 | 2024 | |
| Incyte Corporation | $126.24 | 2025 | Niktimvo |
| Takeda Pharmaceuticals U.S.A., INC. | $124.99 | 2024 | Iclusig |
| Glaxosmithkline, LLC. | $93.92 | 2023 | |
| Astellas Pharma US INC | $83.75 | 2025 | Xospata |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Seto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.